Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Free Cash Flow (2016 - 2025)

Pulmatrix's Free Cash Flow history spans 13 years, with the latest figure at -$706000.0 for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 44.01% year-over-year to -$706000.0; the TTM value through Dec 2025 reached -$5.4 million, up 51.12%, while the annual FY2025 figure was -$5.4 million, 51.12% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$706000.0 at Pulmatrix, up from -$1.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$706000.0 in Q4 2025 and bottomed at -$6.5 million in Q2 2021.
  • The 5-year median for Free Cash Flow is -$3.8 million (2022), against an average of -$3.6 million.
  • The largest annual shift saw Free Cash Flow tumbled 882.76% in 2021 before it skyrocketed 66.3% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$4.4 million in 2021, then dropped by 14.31% to -$5.1 million in 2022, then surged by 59.86% to -$2.0 million in 2023, then surged by 37.85% to -$1.3 million in 2024, then surged by 44.01% to -$706000.0 in 2025.
  • Per Business Quant, the three most recent readings for PULM's Free Cash Flow are -$706000.0 (Q4 2025), -$1.0 million (Q3 2025), and -$1.9 million (Q2 2025).